Trial Profile
Add-on empagliflozin in type 2 diabetics with CKD stage 3A, 3B and 4
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2013
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Sep 2013 New trial record